Voloridge Investment Management, LLC Intra Cellular Therapies, Inc. Transaction History

Voloridge Investment Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$52.09 - $64.1 $2.6 Million - $3.2 Million	49,887 New	49,887 $2.6 Million
Q2 2022 Aug 15, 2022	BUY	$43.0 - $65.64 $3.98 Million - $6.07 Million	92,506 New	92,506 $5.28 Million
Q4 2020 Feb 16, 2021	SELL	$23.34 - $32.22 $678,680 - $936,893	-29,078 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$17.61 - $31.86 $512,063 - $926,425	29,078 New	29,078 $746,000
Q2 2020 Aug 14, 2020	SELL	$14.35 - $26.64 $646,367 - $1.2 Million	-45,043 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$12.31 - $33.12 $818,147 - $2.2 Million	-66,462 Reduced 59.6%	45,043 $692,000
Q4 2019 Feb 14, 2020	BUY	$7.26 - $38.49 $552,769 - $2.93 Million	76,139 Added 215.29%	111,505 $3.83 Million
Q3 2019 Nov 14, 2019	BUY	$7.47 - $14.03 $264,184 - $496,184	35,366 New	35,366 $264,000

381

84M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $11.9B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.